There are very few studies in ruminants characterizing mammary and adipose tissue (AT) expression of genes and gene networks for diets causing variations in milk fatty acid (FA) composition without altering milk fat secretion, and even less complementing this information with data on tissue FA profiles. This work was conducted in sheep to investigate the response of the mammary gland and the subcutaneous and perirenal AT, in terms of FA profile and mRNA abundance of genes involved in lipid metabolism, to a diet known to modify milk FA composition.
Ten lactating Assaf ewes were randomly assigned to 2 treatments consisting of a total mixed ration based on alfalfa hay and a concentrate (60:40) supplemented with 0 (control diet) or 25 (SO diet) g of sunflower oil/kg of diet DM for 7 weeks. Milk composition, including FA profile, was analysed after 48 days on treatments. On day 49, the animals were euthanized and tissue samples were collected to analyse FA and mRNA abundance of 16 candidate genes. Feeding SO did not affect animal performance but modified milk FA composition. Major changes included decreases in the concentration of FA derived from de novo synthesis (e.g., 12:0, 14:0 and 16:0) and increases in that of long chain FA (e.g., 18:0, c9-18:1, trans-18:1 isomers and c9,t11-CLA) but they were not accompanied by significant variations in the mRNA abundance of studied lipogenic genes (i.e., ACACA, FASN, LPL, CD36, FABP3, SCD1 and SCD5) and transcription factors (SREBF1 and PPARG), or in the constituent FA of mammary tissue. Regarding the FA composition of AT, the little influence of SO did not appear to be linked to changes in gene mRNA abundance (decreases of GPAM and SREBF1 in both tissues, and of PPARG in the subcutaneous depot). Similarly, the great variation between AT (higher contents of saturated FA and trans-18:1 isomers in the perirenal, and of cis-18:1, c9,t11-CLA and n-3 PUFA in the subcutaneous AT) could not be related to differences in gene mRNA abundance due to tissue site (higher LPL and CD36, and lower SREBF1 in perirenal than in subcutaneous AT). Overall, these results suggest a marginal contribution of gene expression to the nutritional regulation of lipid metabolism in these tissues, at least with the examined diets and after 7 weeks on treatments. It cannot be ruled out, however, that the response to SO is mediated by other genes or post-transcriptional mechanisms.
Introduction
The addition of a moderate amount of sunflower oil (SO) to a forage-rich diet has proved in dairy ewes to modulate milk fat composition without negatively affecting its production (Toral et al., 2010; Gómez-Cortés et al., 2011) . However, mechanisms explaining changes in milk fatty acids (FA), including mediation via coordinated down-and up-regulation of genes involved in lipid metabolism, are still poorly understood. In addition, there are very few studies characterizing mammary expression of genes and gene networks for diets causing variations in milk FA composition without altering milk fat secretion (Shingfield et al., 2010) . The available information is almost limited to cows suffering milk fat depression (MFD; Piperova et al., 2000; Peterson et al., 2003) or to goats (Bernard et al., 2005a (Bernard et al., , 2005b (Bernard et al., and 2009a , a species in which this syndrome is not often observed, but little work has been published yet on ewes (Dervishi et al., 2012; Bichi et al., 2013) .
Whereas the physiological adaptations of the mammary gland or adipose tissues (AT) occurring during lactation have been well described in ruminants (Vernon, 1980; Chilliard, 1999; Bauman, 2000) , the possible contribution of AT to the regulation of mammary lipogenesis still needs to be documented (Shingfield et al., 2010) . Studies on diet-induced MFD in cows report an increase in the mRNA abundance of lipogenic genes in AT related to the preferential partitioning of nutrients towards non-mammary tissues (Harvatine et al., 2009; Thering et al., 2009; Schmitt et al., 2011) . On the contrary, lipid supplementation inducing no changes or increases in milk fat yield in goats is not accompanied by alterations of the mRNA abundance or activity of lipogenic enzymes in AT (Bernard et al., 2005a and 2009a) . Although it is complicated to discern whether these differences are linked to the diet, its interaction with species, or other factors, there is no information at all in sheep.
Furthermore, most works relied on the study of subcutaneous AT (Harvatine et al., 2009; Thering et al., 2009; Bichi et al., 2013) , despite differences among AT in FA composition, lipogenic gene expression or enzyme activity have been described (Chilliard et al., 1981; Bas et al., 1987; Barber et al., 2000) . Data on the FA profile of AT could complement results on gene mRNA abundance to improve our understanding of lipid metabolism, but simultaneous measurements are seldom reported (Toral et al., 2013) . Similarly, most studies last for up to only 4 weeks (Piperova et al., 2000; Bernard et al., 2009b; Jacobs et al., 2011) and mechanisms involved in a longer term response are not considered. On the other hand, according to previous results in dairy ewes (e.g., Toral et al., 2010; Gómez-Cortés et al., 2011) , the longer the time on lipid-supplemented diets, the greater the differences in milk fat composition. Therefore, it may be expected that changes in the mRNA abundance of genes involved in lipid metabolism would also be more easily observed after relatively long periods on lipid-treatments.
Thus, an assay with lactating ewes receiving SO for 7 weeks was conducted on the hypothesis that SO-induced changes in milk FA profile would be mediated by variations in mammary lipogenic gene expression, this response being also putatively related to changes in AT.
Materials and methods

Animals, experimental diets and management
Ten multiparous Assaf ewes (84.1 kg BW, s.d. 8.35; 75 days in milk, s.d. 3.7) were divided into two groups (n=5), balanced for milk yield, BW, days in milk, and number of lactation, and assigned to one of two experimental treatments (diets): control and supplemented with SO. Diets, prepared weekly, consisted of a total mixed ration (TMR) based on dehydrated alfalfa hay (particle size>4 cm) and a concentrate (60:40) supplemented with 0 (control diet) or 25 (SO diet) g of SO/kg of diet dry matter (DM). The ingredients and chemical composition of the experimental diets, which included molasses to reduce selection of dietary components, are given in Table 1 . Clean water was always available and fresh diets were offered daily ad libitum at 0900 and 1900 h.
Ewes were milked twice daily at approximately 0830 and 1830 h in a 1x10 stallmilking parlour (DeLaval, Madrid, Spain). The experiment lasted for 7 weeks and was carried out in accordance with the Spanish Royal Decree 1201/2005 for the protection of animals used for experimental purposes.
Measurements and sampling procedures
Representative samples of offered and refused diets were collected weekly, stored at −20ºC and then freeze-dried. Diet samples were analyzed for DM, ash, CP, NDF, ADF and ether extract as outlined in Toral et al. (2010) .
On day 48 of the experiment, individual milk yield was recorded both at morning and evening milkings, and milk samples were collected from each animal and stored at 4ºC with a preservative (bronopol) until analyzed for fat, CP, lactose and total solids by infrared spectrophotometry as described in Toral et al. (2010) . Milk fat composition was determined in unpreserved samples stored at −30ºC.
At the end of the experiment (day 49), the ewes were slaughtered humanely by an intravenous injection of a euthanasia drug (T-61, Intervet, Salamanca, Spain; 0.1 mL/kg BW) and samples of the mammary secretory tissue, and subcutaneous (abdomen) and perirenal AT were collected under sterile conditions, immediately frozen in liquid N 2 and stored at -80ºC until lipid and RNA extraction.
Lipid analysis
Fatty acid methyl esters (FAME) of lipid in TMR and milk were prepared in a one-step extraction-transesterification procedure, as outlined previously by Shingfield et al. (2003) . Total lipids in 500 mg of mammary secretory tissue and in 30 mg of subcutaneous and perirenal AT were extracted (Folch et al., 1957) , and converted to FAME using a base-acid catalyzed transesterification procedure (Glass, 1971) .
Methyl esters were separated and quantified by gas chromatography using a temperature gradient programme, and isomers of 18:1 were further resolved in a separate analysis under isothermal conditions (Shingfield et al., 2003) . Peaks were identified based on retention time comparisons with authentic standards (from NuChek Prep., Elysian, MN, USA; SigmaAldrich, Madrid, Spain; and Larodan Fine Chemicals AB, Malmö, Sweden), and milk samples for which the FA composition was determined based on gas chromatography analysis of FAME and GC-MS analysis of corresponding 4,4-dimethyloxazoline derivatives (Shingfield et al., 2006) .
RNA isolation and quantitative PCR
Total RNA from each tissue was isolated and purified further as described in Bernard et al. (2005b) . Concentration and purity of RNA was determined by spectrophotometry using a Nano-Drop ND-1000 spectrophotometer (Nano-Drop Technologies, Wilmington, DE, USA). The RNA integrity was evaluated using the Agilent Bioanalyzer system (Agilent Technologies, Santa Clara, CA, USA), the RIN value for all the samples being 7.2 ± 0.14. Reverse transcription qPCR was carried out (Bernard et al., 2005b) using specific primers and probes (Supplementary Table   S1 ) for the following genes: acetyl-CoA carboxylase alpha (ACACA) and fatty acid synthase (FASN), involved in de novo FA synthesis; lipoprotein lipase (LPL), thrombospondin receptor or fatty acid translocase (CD36) and fatty acid-binding proteins 3 (FABP3) and 4 (FABP4), involved in the uptake and intracellular transport of FA; stearoyl-CoA desaturase (SCD1 and SCD5), involved in Δ9-desaturation of FA; glycerol-3-phosphate acyltransferase (GPAM), involved in the esterification of FA to glycerol; carnitine palmitoyl transferase 2 (CPT2), involved in the mitochondrial oxidation of FA; fatty acid elongases 5 and 6 (ELOVL5 and ELOVL6) , involved in the elongation to very long-chain and long-chain FA respectively; milk fat globule-EGF factor 8 (MFGE8) and xanthine dehydrogenase (XDH), encoding two of the major proteins of the milk fat globule membrane; and the transcription factors: sterol regulatory element binding transcription factor 1 (SREBF1) and peroxisome proliferator-activated receptor gamma (PPARG). To account for variations in RNA integrity, RNA quantification and cDNA synthesis, mRNA abundance was normalized using the geometric mean of three housekeeping genes: peptidylprolyl isomerase A (PPIA), ubiquitiously-expressed transcript (UXT) and eukaryotic translation initiation factor 3 subunit K (EIF3K), which were identified as suitable internal controls among several tested (Bonnet et al., 2013) . Abundance of gene transcripts was expressed as the log value of mRNA copy number relative to the geometric mean of the three housekeeping genes.
Statistical analysis
All statistical analyses were performed using the MIXED procedure of the SAS software package (version 9.3, SAS Inst. Inc., Cary, NC, USA). Data of diet composition, animal performance, milk and mammary FA profiles, as well as mammary mRNA abundances of candidate genes were analysed by a one-way ANOVA with a statistical model that included the fixed effect of the diet. Two-way ANOVA was applied to data of FA composition and gene mRNA abundance of AT, the statistical model including the fixed effects of the diet, the adipose site and their interaction. In both cases, animals were nested within the treatment and used as the error term to contrast the effect of SO supplementation. Differences between means were evaluated using the 'pdiff option' of the 'LS means' statement of the MIXED procedure. They were declared significant at P<0.05 and considered as tendencies toward significance at P<0.10. Least square means are reported throughout.
Results
Animal performance and milk FA composition and secretion
The inclusion of SO did not affect any of the animal performance parameters studied (i.e. DM intake, calculated energy balance, milk yield and milk fat, protein, lactose and total solid composition and yields; Table 2 ; P>0.10).
In contrast, as shown in Table 3 The effect of dietary treatment on milk FA secretion is presented in Table 4 . The inclusion of SO significantly augmented the yield of >16-carbon FA, while no effect was detected on 16-carbon, and <16-carbon FA tended to be reduced (P<0.10).
Reflecting the effects reported for milk FA concentrations, the secretion of 18:0, some 18:1 isomers, and total CLA (particularly c9,t11-CLA) was higher with the SO diet. On the other hand, SO supplementation did not affect saturates, odd-and branched-chain FA (OBCFA) and PUFA n-6 secretion (P>0.10).
Mammary and adipose tissue FA composition
Most of the diet-induced differences observed in milk FA composition were not detected in the mammary secretory tissue (Table 3 and Supplementary Table S3) , where changes due to SO were limited to a tendency (P<0.10) to a reduction of some OBCFA (17:0, anteiso-17:0 and iso-18:0) and a rise in some trans isomers (t5-to t9-18:1 and t9,c12-18:2). Major differences in the FA composition of AT were related to the effect of tissue site rather than to dietary treatment (Table 5 and Supplementary   Table S4 ). The subcutaneous AT was richer in OBCFA, unsaturated FA, especially Δ9-desaturase products, other cis-18:1 and CLA isomers, and 20-and 22-carbon PUFA n-3 and n-6 (P<0.05), while the perirenal AT showed a higher content of 18:0 and trans-18:1 (P<0.01). Some of the few differences in FA profile due to dietary treatments (P<0.05) were in line with those mentioned for the mammary tissue (e.g., the decrease in 17:0 and 18:3n-3). Significant interactions between the effects of tissue site and diet were only observed for minor FA (namely t9,c12,c15-18:3 and iso-16:0; Table 5 ).
mRNA abundances of candidate genes in mammary and adipose tissues
The mRNA abundance of some candidate genes (Tables 6, 7 and S5) was tissuespecific: MFEG8, XDH and FABP3 were higher in the mammary tissue and FABP4
and ELOVL6 in AT. The consumption of SO did not significantly affect the mRNA abundance of analysed genes in the mammary tissue but caused a decrease of GPAM and SREBF1 in both AT (P<0.05) and of PPARG in the subcutaneous depot (interaction diet×AT, P<0.05). There were also differences between AT, with SREBF1 being more abundant in the subcutaneous (P<0.01) and LPL (P<0.05) and CD36 (P<0.10) in the perirenal AT. The mRNA abundance of MFGE8 (P<0.001) and FABP3 (P<0.05) also varied between depots but their levels were always very low.
Discussion
Animal performance and milk fatty acid composition and secretion
The present results provide further support that feeding a moderate amount (2.5% DM) of SO modulates milk FA composition in the absence of negative effects on ewe performance (Toral et al., 2010; Gomez-Cortés et al., 2011) . The observed variations in milk FA composition and secretion (lower levels of medium-chain saturated FA, and greater of c9,t11-CLA and t11-18:1) are related to potentially beneficial effects for human health (Shingfield et al., 2008) . Nevertheless, and in contrast to what was expected from previous experiments in ewes fed similar diets (e.g., Toral et al., 2010; Gómez-Cortés et al., 2011) , the addition of SO increased the content of t10-18:1, together with that of t9-and t12-18:1, which might be potentially detrimental to consumers (Shingfield et al., 2008) . Their concentrations, however, were kept relatively low (≤0.48, 0.53 and 0.81% of total FA, respectively).
Mammary lipid metabolism
The tendency to a reduction in the secretion of <16-carbon FA and the lower milk percentages of <16 and 16-carbon FA in response to SO was not associated with changes in the mRNA abundance in the mammary secretory tissue of the candidate genes involved in de novo synthesis (i.e., ACACA and FASN). These results are consistent with data on gene expression and enzymatic activities reported in goats (Bernard et al., 2005b and 2008) The SO treatment also increased the proportion and secretion of milk long-chain FA with no evidences of significant changes in the mRNA abundances of genes related with the uptake, transport and trafficking of long-chain FA in the mammary epithelial cells (i.e., LPL, CD36 and FABP3). These findings are consistent with previous research in dairy goats fed plant oils (Bernard et al., 2009a and 2009b; Ollier et al., 2009) , suggesting that, in the absence of MFD, diet-induced changes in the content of milk long-chain FA might not be mediated by changes in the mRNA abundance of these particular candidate genes. They would also suggest that other regulation mechanisms, such as post-transcriptional events linked to higher availability of 18-carbon FA, may be involved (Bernard et al., 2008) . Nonetheless, given the high interindividual variation in gene expression and the low statistical power of the experiment, it cannot be ruled out that changes are also mediated by modifications in the candidate genes occurring below the level of detection.
With regard to Δ9-desaturation, despite SO modified the milk content of several substrates for (14:0, 16:0, 18:0 and t11-18:1) and products of (c9-18:1 and c9,t11-CLA) mammary SCD, no variation in the milk Δ9-desaturase indexes (used as a proxy for the SCD activity) was observed, indicating that the SO treatment did not affect the activity of this enzyme. In the same way, no changes in the mRNA abundance of SCD1 and SCD5 were detected, suggesting that variations in the availability of substrates did not have a significant effect on the transcription of these genes.
This weak relationship between mammary SCD mRNA abundance and Δ9-desaturase activity suggests a greater relevance of post-transcriptional regulatory events, such as mRNA stability, initiation of translation or turnover and activity regulation of the enzymatic protein, as observed in rodents (Ntambi, 1999) and ruminants (Bernard et al., 2013) .
Concerning the FA profile of the mammary tissue, there is very little literature reporting this data in ruminants (Christie, 1981; Toral et al., 2013) and no information is available in lactating ewes. In the present study, the virtual absence of shorterchain FA (4 to 9 carbons, which are present in the milk) would suggest not only that residual milk was well removed but also a minor contribution of unsecreted cytosolic lipid droplets to extracted lipids. Nevertheless, the few changes detected in the longer-chain FA in response to SO treatment suggest that variations in milk FA profile and secretion had no significant reflect in mammary FA composition, as previously observed in goats (Toral et al., 2013) .
Adipose tissue lipid metabolism
Few changes were observed in lipogenic gene expression in subcutaneous and perirenal AT in response to SO treatment, which agrees with the lack of variation in energy balance and milk fat secretion, and with data reported in cows and goats (Shingfield et al., 2010) . However, the mRNA abundance of SREBF1 (which might have a central role in lipid synthesis; Harvatine et al., 2009 ) was decreased in response to SO in both AT ( Table 7) , and that of PPARG in the subcutaneous depot.
Although changes in these transcription factors have been related with the up-or down-regulation of several lipogenic genes (Harvatine et al., 2009; Schmitt et al., 2011) , no effect of SO on the mRNA abundance of genes related to lipogenesis was detected in the present study, and only GPAM mRNA showed a coordinated downregulation. Yet, since GPAM is involved in the esterification of FA to glycerol, this can hardly be related with the few effects of dietary SO on the FA composition of AT (reductions in 18:3n-3 and 17:0), which were probably caused by potential reductions in their availability for tissue uptake, as a result of the negative impact of SO on their ruminal concentration (Toral et al., 2012) . Putative effects of SO on the availability of other long-chain FA, as inferred from their changes in milk fat, or in the rumen fluid of ewes fed similar diets (Toral et al., 2012) had no substantial consequences on AT composition. Previous data in cows showed that a high availability of exogenous FA (through duodenal infusion of rapeseed oil) had no effect on AT lipogenic activities during early lactation but caused a reduction after the lactation peak, when the activity was observed to increase in cows receiving the control diet due to variation in the energy balance (Chilliard et al, 1991) . The few changes observed in the present study in mid-lactation ewes in positive energy balance are likely a result of the relatively low amount of supplemental SO.
When comparing AT, the greater content of saturated FA (mainly 18:0) and trans-18:1 isomers (t11-and t12-18:1) in the perirenal AT, and of cis-18:1, c9,t11-CLA and n-3 PUFA in the subcutaneous AT, are in line with previous data in ruminants (Christie, 1981; Bas et al., 1987) . These specificities due to tissue site have also been correlated with a depot-specific expression of lipogenic genes (Barber et al., 2000; Bernard et al., 2005a) . However, the higher proportion of Δ9-desaturase products (mainly c9-14:1, c9-16:1, c9-17:1, c9-18:1 and c9,t11-CLA) and the lower proportion of Δ9-desaturase substrates (mainly 18:0 and t11-18:1) observed in subcutaneous compared to perirenal AT, were not associated with differences in tissue mRNA abundance of SCD1, which is consistent with previous research in nonlactating sheep (Barber et al., 2000) but not in goats (Bernard et al., 2005b) . Subcutaneous and perirenal AT exhibited different levels of LPL and CD36 mRNA, suggesting potential divergences in FA uptake. The higher abundance of LPL transcripts in the perirenal AT is in line with results of the corresponding enzyme activity in lactating goats (Chilliard et al., 1981; Bernard et al., 2005a) and cows (Chilliard and Robelin, 1985) . The lack of significant variation due to SO is also consistent with previous data in goats fed soybeans (Bernard et al., 2005a) .
Altogether, these results show only marginal changes in the mRNA abundance of the candidate genes and related transcription factors in AT. Although it cannot be dismissed that the lack of more significant differences is due to statistical power limitations of the experiment, they agree with previous observations in goats fed plant lipids (Bernard et al., 2005a and 2009a) and in sheep fed marine algae (Bichi et al., 2013) for which, respectively, an increase and a decrease of milk fat yield were observed.
Conclusions
This study provides novel and complementary information on the response to diet supplementation with SO in terms of milk FA composition and secretion, and FA profile and lipogenic gene expression of mammary and adipose tissues in lactating ewes. Dietary inclusion of a moderate amount (2.5% DM) of SO for 7 weeks modifies the FA profile of the milk but has only slight effects on that of mammary and adipose tissues. No relationship is detected between these changes and results on mammary mRNA abundance of the candidate genes and transcription factors involved in lipid metabolism. Neither the marginal repercussion of SO feeding on the gene expression in subcutaneous and perirenal AT, after 7 weeks on the diet, is related with differences in FA profile between adipose sites or with milk fat secretion.
Nevertheless, it cannot be ruled out that the response to linoleic-rich diets is mediated by other genes, post-transcriptional mechanisms, or particularly the availability of FA of dietary origin, which would support the need of further studies. 3 Sum of t7,t9-CLA + t8,t10-CLA + t9,t11-CLA + t10,t12-CLA. 4 Contains t11,t15-18:2 as a minor component. ].
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